{"nct_id":"NCT03677596","title":"A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients","status":"COMPLETED","status_verified_date":"2023-10","start_date":"2019-07-01","start_date_type":"ACTUAL","primary_completion_date":"2022-09-21","primary_completion_date_type":"ACTUAL","completion_date":"2023-05-26","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["PFE"]}